Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day −1 ) in the treatment of cutaneous or lymphocutaneous sporotrichosis
Chapman, S. W.; Pappas, Peter G.; Kauffmann, C.; Smith, E. B.; Dietze, R.; Tiraboschi-Foss, N.; Restrepo, A.; Bustamante, A. B.; Opper, C.; Emady-Azar, S.; Bakshi, R. (Blackwell Verlag, GmbH, 2004-02)
(105.4KB)